Tecan Group Future Growth
Future criteria checks 3/6
Tecan Group is forecast to grow earnings and revenue by 14.9% and 6.3% per annum respectively. EPS is expected to grow by 16.2% per annum. Return on equity is forecast to be 9.4% in 3 years.
Key information
14.9%
Earnings growth rate
16.2%
EPS growth rate
Life Sciences earnings growth | 19.9% |
Revenue growth rate | 6.3% |
Future return on equity | 9.4% |
Analyst coverage | Good |
Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,096 | 128 | 135 | 180 | 8 |
12/31/2025 | 1,017 | 107 | 139 | 181 | 8 |
12/31/2024 | 945 | 74 | 114 | 151 | 7 |
6/30/2024 | 1,000 | 101 | 93 | 122 | N/A |
3/31/2024 | 1,037 | 117 | 109 | 141 | N/A |
12/31/2023 | 1,074 | 132 | 126 | 161 | N/A |
9/30/2023 | 1,088 | 120 | 114 | 151 | N/A |
6/30/2023 | 1,102 | 109 | 101 | 140 | N/A |
3/31/2023 | 1,123 | 115 | 97 | 134 | N/A |
12/31/2022 | 1,144 | 121 | 92 | 128 | N/A |
9/30/2022 | 1,110 | 113 | 91 | 129 | N/A |
6/30/2022 | 1,077 | 105 | 89 | 129 | N/A |
3/31/2022 | 1,012 | 113 | 110 | 149 | N/A |
12/31/2021 | 947 | 122 | 130 | 170 | N/A |
9/30/2021 | 911 | 136 | 163 | 203 | N/A |
6/30/2021 | 875 | 150 | 195 | 237 | N/A |
3/31/2021 | 803 | 127 | 181 | 223 | N/A |
12/31/2020 | 731 | 104 | 167 | 208 | N/A |
9/30/2020 | 691 | 94 | 142 | 177 | N/A |
6/30/2020 | 651 | 84 | 118 | 146 | N/A |
3/31/2020 | 644 | 79 | 96 | 122 | N/A |
12/31/2019 | 637 | 73 | 75 | 99 | N/A |
9/30/2019 | 627 | 70 | 70 | 95 | N/A |
6/30/2019 | 616 | 67 | 65 | 90 | N/A |
3/31/2019 | 605 | 69 | 66 | 92 | N/A |
12/31/2018 | 594 | 71 | 67 | 93 | N/A |
9/30/2018 | 582 | 70 | 75 | 99 | N/A |
6/30/2018 | 570 | 69 | 84 | 106 | N/A |
3/31/2018 | 559 | 67 | N/A | 103 | N/A |
12/31/2017 | 549 | 66 | N/A | 99 | N/A |
9/30/2017 | 536 | 62 | N/A | 93 | N/A |
6/30/2017 | 523 | 57 | N/A | 86 | N/A |
3/31/2017 | 515 | 56 | N/A | 102 | N/A |
12/31/2016 | 506 | 55 | N/A | 119 | N/A |
9/30/2016 | 491 | 55 | N/A | 124 | N/A |
6/30/2016 | 476 | 55 | N/A | 129 | N/A |
3/31/2016 | 458 | 56 | N/A | 114 | N/A |
12/31/2015 | 440 | 57 | N/A | 99 | N/A |
9/30/2015 | 434 | 52 | N/A | 83 | N/A |
6/30/2015 | 427 | 48 | N/A | 67 | N/A |
3/31/2015 | 413 | 44 | N/A | 58 | N/A |
12/31/2014 | 400 | 40 | N/A | 48 | N/A |
9/30/2014 | 389 | 44 | N/A | 43 | N/A |
6/30/2014 | 378 | 48 | N/A | 39 | N/A |
3/31/2014 | 383 | 47 | N/A | 33 | N/A |
12/31/2013 | 388 | 46 | N/A | 28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0QLN's forecast earnings growth (14.9% per year) is above the savings rate (2.1%).
Earnings vs Market: 0QLN's earnings (14.9% per year) are forecast to grow faster than the UK market (14.7% per year).
High Growth Earnings: 0QLN's earnings are forecast to grow, but not significantly.
Revenue vs Market: 0QLN's revenue (6.3% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: 0QLN's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0QLN's Return on Equity is forecast to be low in 3 years time (9.4%).